The observation could pave the way for a blood test to predict disease progression in people with a genetic predisposition to developing the neurodegenerative disorder.
Levels of a protein called neurofilament light chain increase in the blood and spinal fluid of some Alzheimer’s patients 16 years before they develop symptoms, according to a study published today (January 21) in Nature Medicine.
Read also: Research paper
Related : Memory Loss Identified Years Before Alzheimer’s Symptoms Appear
How AI can spot Alzheimer’s disease five years before diagnosis